在ICD-10时代利用行政数据识别肝性脑病患者
肝性脑病是肝硬化的常见并发症,需在行政数据中验证识别算法。ICD-9代码572.2对HE的阳性预测值为0.92、阴性预测值为0.36;与肝硬化代码联用算法PPV和NPV分别为0.86和0.87。2015年改用ICD-10后旧算法失效,本研究验证基于ICD-10和药物记录的HE诊断编码算法。
要点
- ICD-9代码572.2对HE的PPV为0.92,NPV为0.36
- ICD-9肝硬化联用算法PPV和NPV分别为0.86和0.87
- 2015年ICD-10启用后基于ICD-9的算法失效,需重新验证
核心结论
- 研究验证了基于ICD-10和药物记录的肝性脑病诊断编码算法。
研究设计与样本
- 本研究为诊断算法验证研究,利用ICD-10编码和药物记录识别肝性脑病患者。
主要发现
- ICD-9代码572.2对HE的阳性预测值为0.92,阴性预测值为0.36。
- ICD-9肝硬化代码联用算法对HE的PPV和NPV分别为0.86和0.87。
- 2015年改用ICD-10后,基于ICD-9验证的算法不再有效。
关键数值与推荐
- ICD-9代码572.2对HE的PPV为0.92,NPV为0.36。
- ICD-9肝硬化联用算法对HE的PPV为0.86,NPV为0.87。
临床怎么用
- 在ICD-10行政数据中识别HE患者需采用基于ICD-10和药物记录验证的新算法。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Hepatic encephalopathy (HE) is a common complication of cirrhosis resulting in relapsing-remitting mental status changes ranging from deficits in executive function to coma. Incident HE is associated with an abrupt increase in mortality1 and frequent hospitalization.2 To further the understanding of the burden and impact of HE at the population level, valid algorithms are required to identify patients in administrative data. An International Classification of Diseases (ICD)-9 code is specific for HE (572.2), offering a 0.92 positive predictive value (PPV) and 0.36 negative predictive value (NPV).3 When applied in an algorithm to patients with ICD-9 codes for cirrhosis (eg, 571.5), Kanwal et al4 found a PPV and NPV of 0.86 and 0.87. Unfortunately, the switch to ICD-10 in 2015 rendered algorithms validated using ICD-9 invalid. Kaplan et al5 previously showed that lactulose and rifaximin use correlated with grade of HE for Child classification. Herein, we validate a diagnostic coding algorithm for HE using ICD-10 and medication records.
引用
- Tapper EB, Korovaichuk S, Baki J, et al. Identifying Patients With Hepatic Encephalopathy Using Administrative Data in the ICD-10 Era. Clin Gastroenterol Hepatol. 2019. PMID: 31887447. doi:10.1016/j.cgh.2019.12.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。